Form 4: Veracyte VP, Chief Accounting Officer Sells 5,032 Shares

Jonathan Wygant, VP and Chief Accounting Officer of Veracyte, Inc., sold 5,032 shares of common stock at an average price of $42.8922 on November 27, 2024.

Summary

• Jonathan Wygant, the VP and Chief Accounting Officer of Veracyte, Inc., sold 5,032 shares of the company's common stock on November 27, 2024.
• The sale was executed at a weighted average price of $42.8922 per share.
• The prices for individual transactions ranged from $42.8028 to $42.9001.
• Following the transaction, Wygant directly owns 42,313 shares of Veracyte common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider stock sale, which is a common occurrence. It does not inherently indicate positive or negative sentiment.

Industry Context

This is a routine SEC Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the trading activities of company officers.

Comparison to Industry Standards

• SEC Form 4 filings are standard practice for publicly traded companies in the United States.
• The sale of shares by a company officer is a common occurrence and does not necessarily indicate a negative outlook for the company.
• Similar filings are made by officers of comparable companies such as Exact Sciences (EXAS) and Guardant Health (GH) when they trade their company's stock.

Stakeholder Impact

• The sale of shares by a company officer may be of interest to shareholders, but it is a routine transaction and does not necessarily indicate a change in the company's prospects.

Key Dates

Keywords

Veracyte, insider trading, stock sale, Jonathan Wygant, VCYT, chief accounting officer, share transaction